| 000 -LEADER |
|---|
| fixed length control field |
04864nam a22005415i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
978-3-211-69459-6 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20161121230845.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
100611s2008 au | s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9783211694596 |
| -- |
978-3-211-69459-6 |
| 024 7# - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
10.1007/978-3-211-69459-6 |
| Source of number or code |
doi |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RC254-282 |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MJCL |
| Source |
bicssc |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED062000 |
| Source |
bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.994 |
| Edition number |
23 |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology |
| Medium |
[electronic resource] : |
| Remainder of title |
Scientific and Clinical Aspects of Anemia in Cancer / |
| Statement of responsibility, etc. |
edited by Mohammad Resa Nowrousian. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
Second, Revised and Enlarged Edition. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Vienna : |
| Name of producer, publisher, distributor, manufacturer |
Springer Vienna, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2008. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
XVIII, 866 p. |
| Other physical details |
online resource. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 347 ## - DIGITAL FILE CHARACTERISTICS |
|---|
| File type |
text file |
| Encoding format |
PDF |
| Source |
rda |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Physiology of erythropoiesis -- Biology of EPO and EPO-receptor -- The role of erythropoietin receptor expression on tumor cells -- Problems associated with erythropoietin receptor determination on tumor cells -- Definition, classification and characterization of anemia in cancer -- Pathophysiology of anemia in cancer -- Prevalence and incidence of anemia and risk factors for anemia in patients with cancer -- Significance of anemia in cancer chemotherapy -- Incidence and impact of anemia in radiation oncology -- Relationship between hemoglobin levels and tumor oxygenation -- Tumor hypoxia and therapeutic resistance -- Symptoms of anemia -- Impact of anemia and red blood cell transfusion on organ function -- Relationship of hemoglobin, fatigue, and quality of life in anemic cancer patients -- When to use red blood cell transfusions in cancer patients with solid tumours? -- Pharmacology, pharmacokinetics and safety of recombinant human erythropoietin preparations -- Epoetin treatment of anemia associated with multiple myeloma and non-Hodgkin’s lymphoma -- rhEPO in anemic patients with solid tumors and chemotherapy — efficacy and safety -- Early intervention with recombinant human erythropoietin for chemotherapy-induced anemia -- Recombinant human erythropoietin (rhEPO) therapy in myelodysplasia -- Prediction of response to rhEPO in the anemia of cancer -- rhEPO in hematopoietic stem cell transplantation -- Treatment of anemia with rhEPO in radiation oncology -- Recombinant human erythropoietin in pediatric oncology -- rhEPO in surgical oncology -- Erythropoiesis, iron metabolism and iron supplementation during erythropoietin therapy -- Are there risks for use of iron in cancer patients? -- Metabolic and physiologic effects of rhEPO in anemic cancer patients -- Effects of rhEPO on quality of life in anemic cancer patients -- Thrombosis during therapy with erythropoiesis stimulating agents in cancer -- The effect of rhEPO on survival in anemic cancer patients -- From bench to bedside: Neuroprotective effects of erythropoietin -- rhEPO in patients with anemia and congestive heart failure -- Cost-effectiveness of treating cancer anaemia. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Anemia is a frequent complication of cancer and its treatment. It produces many symptoms and significantly impairs metabolic and physiologic functions as well as patients' activity, well-being and quality of life. Life expectancy is also affected. This book, now being published in its second edition, comprehensively presents the current knowledge on anemia in cancer and its treatment with rhEPO. Future developments are also discussed. Based on updated and new chapters, including a broader spectrum of topics, outstanding international experts describe the scientific and clinical aspects of anemia in various fields of oncology and give diagnostic and therapeutic recommendations on when and how to use rhEPO. The book, considered as a standard work, will again serve as an essential source of information for radiotherapists, medical oncologists, hematologists, internists, pediatricians, surgeons, specialists in transfusion and laboratory medicine, and pharmacologists. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Medicine. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmacology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Radiotherapy. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Blood transfusion. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Hematology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Oncology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Surgery. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Medicine & Public Health. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Oncology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Radiotherapy. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Hematology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Surgery. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmacology/Toxicology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Blood Transfusion Medicine. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Nowrousian, Mohammad Resa. |
| Relator term |
editor. |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY |
|---|
| Title |
Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Relationship information |
Printed edition: |
| International Standard Book Number |
9783211252239 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
http://dx.doi.org/10.1007/978-3-211-69459-6 |
| 912 ## - |
|---|
| -- |
ZDB-2-SME |
